Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.

Marini S, Crawford K, Morotti A, Lee MJ, Pezzini A, Moomaw CJ, Flaherty ML, Montaner J, Roquer J, Jimenez-Conde J, Giralt-Steinhauer E, Elosua R, Cuadrado-Godia E, Soriano-Tarraga C, Slowik A, Jagiella JM, Pera J, Urbanik A, Pichler A, Hansen BM, McCauley JL, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Testai FD, Kittner SJ, Schmidt H, Enzinger C, Deary IJ, Rannikmae K, Samarasekera N, Salman RA, Sudlow CL, Klijn CJM, van Nieuwenhuizen KM, Fernandez-Cadenas I, Delgado P, Norrving B, Lindgren A, Goldstein JN, Viswanathan A, Greenberg SM, Falcone GJ, Biffi A, Langefeld CD, Woo D, Rosand J, Anderson CD; International Stroke Genetics Consortium.

JAMA Neurol. 2019 Feb 6. doi: 10.1001/jamaneurol.2018.4519. [Epub ahead of print]

PMID:
30726504
2.

MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.

Lu H, Wei M, Zhai Y, Li Q, Ye Z, Wang L, Luo W, Chen J, Lu Z.

J Mol Med (Berl). 2019 Feb 6. doi: 10.1007/s00109-018-01738-w. [Epub ahead of print]

PMID:
30725119
3.

International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.

Pereira NL, So D, Bae JH, Chavez I, Jeong MH, Kim SW, Madan M, Graham J, O'Cochlain F, Pauley N, Lennon RJ, Bailey K, Hasan A, Baudhuin LM, Bell MR, Lerman A, Goodman S, Mathew V, Farkouh M, Rihal CS.

Pharmacogenet Genomics. 2019 Feb 4. doi: 10.1097/FPC.0000000000000368. [Epub ahead of print]

PMID:
30724853
4.

Renal Sodium Excretion Consequent to Pharmacogenetic Activation of Gq-DREADD in Principal Cells.

Mironova E, Suliman F, Stockand JD.

Am J Physiol Renal Physiol. 2019 Feb 6. doi: 10.1152/ajprenal.00612.2018. [Epub ahead of print]

PMID:
30724104
5.

Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.

Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G; ITALSGEN Consortium; International ALS Genomics Consortium, Tienari PJ, Stone DJ, Nalls MA, Singleton AB, ChiĆ² A, Traynor BJ.

Ann Neurol. 2019 Feb 5. doi: 10.1002/ana.25431. [Epub ahead of print]

PMID:
30723964
6.

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.

Germain DP, Nicholls K, Giugliani R, Bichet DG, Hughes DA, Barisoni LM, Colvin RB, Jennette JC, Skuban N, Castelli JP, Benjamin E, Barth JA, Viereck C.

Genet Med. 2019 Feb 6. doi: 10.1038/s41436-019-0451-z. [Epub ahead of print]

PMID:
30723321
7.

Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose.

Viglione A, Chiarotti F, Poggini S, Giuliani A, Branchi I.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0080-6. [Epub ahead of print]

PMID:
30723316
8.

Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.

Martin-Guerrero I, Gutierrez-Camino A, Echebarria-Barona A, Astigarraga I, Garcia de Andoin N, Navajas A, Garcia-Orad A.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0081-5. [Epub ahead of print]

PMID:
30723315
9.

Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.

Cuevas S, Villar VAM, Jose PA.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0082-4. [Epub ahead of print]

PMID:
30723314
10.

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.

Del Re M, Cinieri S, Michelucci A, Salvadori S, Loupakis F, Schirripa M, Cremolini C, Crucitta S, Barbara C, Di Leo A, Latiano TP, Pietrantonio F, Di Donato S, Simi P, Passardi A, De Braud F, Altavilla G, Zamagni C, Bordonaro R, Butera A, Maiello E, Pinto C, Falcone A, Mazzotti V, Morganti R, Danesi R.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0077-1. [Epub ahead of print]

PMID:
30723313
11.

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.

Liu R, Zeng Y, Zhou CF, Wang Y, Li X, Liu ZQ, Chen XP, Zhang W, Zhou HH.

Sci Rep. 2017 Feb 2;7(1):18. doi: 10.1038/s41598-017-00050-w.

Supplemental Content

Loading ...
Support Center